InteliFUSE, a New Orleans-based orthopedic surgical device manufacturer that markets StimuLINK, accused Biomedical Enterprises of patent infringement. Under the settlement, the InteliFUSE patents under question were acknowledged as valid and enforceable patents.
The StimuLINK is a shape memory mini-implant designed for use in many orthopedic indications, including surgeries of the foot, ankle, hand and wrist. The device replaces plates, screws, rods, nails and wires.
Read the InteliFUSE news release on the patent infringement settlement.
Read other coverage on patent infringement cases:
– NuVasive Initiates Patent Infringement Lawsuit Against Globus Medical
– Stryker Files Patent Infringement Lawsuit Against Zimmer Holdings
– NuVasive Settles Patent Dispute With Orthofix, Includes $2M Settlement
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
